| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |